Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Information Technology| May 09, 2019

Seeing Technology For What It Is

artificial intelligence

Photo Courtesy of Pixabay

I miss the days when the difference between meaningful and meaningless was apparent; when the line separating relevant and irrelevant was easily drawn. I miss when truth mattered. When the old joke was just a joke: “How do you know when (the person, often a politician) is lying. His lips are moving.”

Today the joke is on us. All of us.

Conspiracy theories may have been around as long as anyone can remember — but today they have become mainstream. We Americans have come to believe in extremes. That goes for good as well as bad.

“Patient first” may be one of them. Noble? Yes. Inspiring? You bet. But, human nature being what it is, can it be achieved? Not, apparently, by Purdue Pharma.

If the maker of Oxycontin had practiced what it preached — commitment “to advancing the medical care of patients” — the opioid crisis might not have happened. But is this pharmaceutical vendor indicative of health care?


Giving Credit Where Credit Is Due

A few years ago I attended an industry banquet where the main speaker talked about how lucky we are to be in such an altruistic profession. He was right, of course. We don’t have the rip currents of the tobacco industry. Our jobs focus on technology that visualizes disease. What could be better than that? Exploratory surgery? Fuhgetaboutit.

But there is a dark side.

We like to think modern medicine invented old age. It didn’t. If it did, life expectancy in this country would be going up. It is not. The tale of Purdue Pharma is an example.

Believing that pills can remedy pain has contributed to drug overdose, one of two key drivers for this country’s recent decline in life expectancy, according to the Centers for Disease Control. (The other, according to the CDC, is a rise in suicides — another topic worthy of discussion but beyond the scope of this article.)

A century ago, an influenza pandemic killed 675,000 Americans, nose-diving average life expectancy of U.S. newborns to just 39 years. By 2013, life expectancy had risen 40 years. In 2017 it was at 78.6; down from 78.7 the year before. Life expectancy in this country is dropping.

Will believing that vaccinations do more harm than good lead to further declines? The ongoing measles epidemic could be a wakeup call. But will it be?

In a broader sense, will we — technology’s advocates — become realistic? Will we understand — and embrace — the concept that the influence of modern medical technology depends on people?


What Technology Can and Cannot Do

Imaging can help us see disease. But it alone is not the answer. The use of imaging machines is just one step in a long journey. The other steps involve myriad aspects of health care, some of which have been around for a long time. None has been sufficient in itself.

Decades before Roentgen promoted the use of X-rays to look inside the human body, hand washing and disinfectants dramatically changed the practice of surgery, even everyday life. Thanks to germ theory, people around the world came to recognize that germs cause infectious disease. Yet in 1918 the H1N1 influenza virus infected 500 million people — about a third of the world population — and caused about 50 million deaths.


Fear As A Driving Force

It was fear that drove the development of vaccines, fear of influenza, measles, hepatitis, diphtheria and polio, to name a few. But even the development of vaccines was not enough, as evidenced by the current measles outbreak. We’ve come to expect the good without effort.

We continue to worship at the altar of technology as if technology had some god-like power.

We need to recognize and embrace that technology only provides us with tools and that these tools must be used. How we use medical technology is as much a determinant of its effect on health as the technology itself. It stands to reason, therefore, that only through wisdom can people get the most from medical technology.

This is all the more important today as we start looking for answers in a new form of technology; one that some say might ultimately confer wisdom, even embody it. I am referring to artificial intelligence (aka machine learning). This is especially dangerous — not that the technology itself poses danger but rather our attitude toward it.

I am reminded of this by dialogue written hundreds of years ago, dialogue that has as much meaning today as it did then. “The fault, dear Brutus, is not in our stars, but in ourselves …”

Through the line he wrote for Cassius, Shakespeare was saying that people must take responsibility for their actions — or inactions — not simply say that the future is written in the stars. In Shakespeare’s time it was astrology. Today it is technology. The transitive property applies.


Seeing Technology For What It Is

I am not advocating that we throw out technology. Nor that it should be disused. On the contrary, technology should be used. But only for its purpose.

Technology provides tools. It is people who must decide how — and when — to use those tools. This applies regardless of whether the technology offers a look inside the human body or, as in the case of AI, insights drawn from data patterns.


Greg Freiherr is a contributing editor to Imaging Technology News (ITN). Over the past three decades, Freiherr has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

Related Content

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019. Photo by Greg Freiherr

Feature | Radiology Business | July 22, 2019 | By Greg Freiherr
Efforts to reform healthcare are booming, b
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho